These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23085258)

  • 1. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
    Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The socioeconomic impact of drug-related crimes in Chile.
    Fernández M
    Int J Drug Policy; 2012 Nov; 23(6):465-72. PubMed ID: 22608568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let it snow! Let it snow! Let it snow! Estimating cocaine production using a novel dataset based on reported seizures of laboratories in Colombia.
    Leoncini R; Rentocchini F
    Int J Drug Policy; 2012 Nov; 23(6):449-57. PubMed ID: 22621844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic analysis of different cannabis decriminalization scenarios.
    Ogrodnik M; Kopp P; Bongaerts X; Tecco JM
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S309-14. PubMed ID: 26417786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical experience with legalized cannabis.
    Gieringer D
    Addiction; 2012 May; 107(5):875-6. PubMed ID: 22471567
    [No Abstract]   [Full Text] [Related]  

  • 7. An evolving problem: methamphetamine production and trafficking in the United States.
    Shukla RK; Crump JL; Chrisco ES
    Int J Drug Policy; 2012 Nov; 23(6):426-35. PubMed ID: 22943831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why small-scale cannabis growers stay small: five mechanisms that prevent small-scale growers from going large scale.
    Hammersvik E; Sandberg S; Pedersen W
    Int J Drug Policy; 2012 Nov; 23(6):458-64. PubMed ID: 23036648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19.
    Caulkins JP; Kilmer B; MacCoun RJ; Pacula RL; Reuter P
    Addiction; 2012 May; 107(5):865-71. PubMed ID: 21985069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long and winding road to cannabis legalization.
    Van Ours JC
    Addiction; 2012 May; 107(5):872-3. PubMed ID: 22471565
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence-based drug policy: it starts with good evidence and ends with policy reform.
    Nosyk B; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):423-5. PubMed ID: 23159128
    [No Abstract]   [Full Text] [Related]  

  • 13. Additional considerations.
    Nadelmann E; Gutwillig S; Davies J
    Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
    [No Abstract]   [Full Text] [Related]  

  • 14. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.
    Lenton S; Frank VA; Barratt MJ; Dahl HV; Potter GR
    Int J Drug Policy; 2015 Mar; 26(3):257-66. PubMed ID: 25181993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the dollar value of the illicit market for cannabis in New Zealand.
    Wilkins C; Reilly JL; Pledger M; Casswell S
    Drug Alcohol Rev; 2005 May; 24(3):227-34. PubMed ID: 16096126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis social clubs in Belgium: organizational strengths and weaknesses, and threats to the model.
    Decorte T
    Int J Drug Policy; 2015 Feb; 26(2):122-30. PubMed ID: 25179934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two ways of estimating the euro value of the illicit market for cannabis in France.
    Legleye S; Ben Lakhdar C; Spilka S
    Drug Alcohol Rev; 2008 Sep; 27(5):466-72. PubMed ID: 18696293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criminal justice outcomes for cannabis use offences in New Zealand, 1991-2008.
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2012 Nov; 23(6):505-11. PubMed ID: 22521268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 'demand side' estimate of the dollar value of the cannabis black market in New Zealand.
    Wilkins C; Bhatta K; Casswell S
    Drug Alcohol Rev; 2002 Jun; 21(2):145-51. PubMed ID: 12188993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retail price as an outcome measure for the effectiveness of drug law enforcement.
    Bright DA; Ritter A
    Int J Drug Policy; 2010 Sep; 21(5):359-63. PubMed ID: 20083399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.